4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-24-000127
Chief Business Officer sold 9,900 shares at $11.56 ($114,444)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2024-07-10 | Sale 10b5-1 | −9,900 | $11.56 | $114,444 | 227,494 | D |
| Open-market sales · 9,900 sh · avg $11.56 · $114,444 | |||||||
Loading xslF345X05/wk-form4_1720824069.xml…